Since the discovery of the human BK and JC polyomaviruses in human tissue,1 2 their widespread distribution has been well documented.3-10 Primary infection occurs in childhood, but the mode of transmission and clinical picture are still not known. The viruses are thought to persist in the body after infection. Reactivation of both viruses has been shown to occur in people whose immunity has been impaired for some reasonl-'6 and at this time virus is frequently excreted in the urine. Transplacental transmission has already been shown to occur for two animal polyomaviruses: mouse polyoma17 and stump-tailed macaque viruses.18
Since the discovery of the human BK and JC polyomaviruses in human tissue,1 2 their widespread distribution has been well documented.3-10 Primary infection occurs in childhood, but the mode of transmission and clinical picture are still not known. The viruses are thought to persist in the body after infection. Reactivation of both viruses has been shown to occur in people whose immunity has been impaired for some reasonl-'6 and at this time virus is frequently excreted in the urine. Transplacental transmission has already been shown to occur for two animal polyomaviruses: mouse polyoma17 and stump-tailed macaque viruses. 18 Because there is evidence that during pregnancy immunity is depressed,19 the recent survey by Coleman and her colleagues was undertaken.20 In this study more than 1000 women were followed during pregnancy and 40 (3%) were found to be excreting a polyomavirus. Evidence was presented to show that the infections were the result of a reactivation of latent virus and were not primary. In the majority of the 40, reactivation was more likely to be due to JC-virus than BK-virus although the latter also occurred. Serological results indicated that reactivation of JC or BK viruses had occurred in 20 % of the pregnant women, but no evidence was found to suggest transmission of BK-virus to the fetus. The Accepted for publication 16 October 1980 cord bloods of 309 newborn babies were examined for BK-virus-specific IgM and all were negative. This prospective study has provided an abundant source of material for further investigations and in this report we present additional information on the occurrence and persistence of BK-and JC-virusspecific immunoglobulin M (IgM) in sera obtained from the pregnant women who showed evidence of polyomavirus reactivation and in cord or neonatal blood samples from their babies. The persistence of BK-virus-specific IgM for several months in patients immunosuppressed after renal transplantation has already been demonstrated.'4 Jung and his colleagues showed that high titres of haemagglutinationinhibiting (HI) antibodies specific for BK-virus persisted for periods up to 20 months and that specific IgM could be detected during this time.
Patients and methods

SUBJECTS
The group under study in the survey of human polyomavirus in pregnancy by Coleman and colleagues20 consisted of 1235 pregnant women.
Nearly half registered at the antenatal clinic during the first trimester of pregnancy and the others at later stages of gestation. At least two maternal serum samples and the cord or neonatal blood samples were collected from each woman and her baby. 674
The presence of antibody to BK-virus and JC-virus was investigated in sera from 430 of these women. The sera from those with high or rising titres to BK-virus and the cord bloods of their infants were tested for BK-virus-specific IgM. In 40 of the 1235 women, inclusion-bearing cells were found in their urine. Sera from these women and cord blood from their infants were examined for the presence of BK-virus-and JC-virus-specific IgM. HAEMAGGLUTINATION 
BK-VIRUS SEROLOGY
The sera from 430 women in the survey20 were examined for the presence of BK-virus antibody, and 359 (83-5 %) found to have HI antibodies (titres 3 20) . Twenty-seven (6-3 %) had high stable titres to BK-virus (; 640) throughout their pregnancy, 15 (3 5 %) had titres which showed a fourfold increase rising to 640 or greater during pregnancy, and 3 (0-7%) had low titres which showed a fourfold increase in BK-virus antibody, but did not rise to 640. Of the 45 women with high or rising titres to BK-virus, 28 (62 %) had BK-virus-specific IgM staining when tested by FA. At least one serum from each of these 28 women was fractionated on sucrose density gradients and 20 (44%) of them had BK-virusspecific IgM, detected by HI, in the IgM fractions. The sera from 30 women with no IgM specific FA staining were also fractionated but no BK-virusspecific IgM was detected in the appropriate fractions. In the sera from 20 women in which BK-virus IgM was detected by HI, the titres were low (8-32) with the exception of one which had a high BK-virus-IgM titre (! 1024). BK-virus-specific IgM was confirmed Table 4 relates the appearance of JC-virus-specific IgM (confirmed by IEM) to the period of gestation in the seven women. Six of these women had high stable titres of JC-virus antibody and the seventh had high rising titres. In most cases JC-virus-specific IgM persisted for several months and in one patient (patient 5), it was known to have persisted for at least seven months. Two patients had both BK-and JCvirus-specific IgM (patients 9 and 11 in Table 2 and 4 and 6 in Table 4 ). Both had small amounts of JC-and BK-virus-specific IgM confirmed by IEM but only one of these had high concentrations of BK-virusspecific IgG.
Discussion
In our study we found no evidence of primary polyomavirus infection occurring during pregnancy and thus the presence of specific IgM in maternal sera has been assumed to be due to reactivation of latent virus. The persistence of the IgM response in several of the pregnant women seems to indicate that once reactivated the BK-virus or JC-virus infection continues at least until delivery. Because we do not have a control group of normal non-pregnant women in the same age range, we do not know if reactivation the first to report on the occurrence of BK-virusspecific IgM during pregnancy. They found it in four of the 80 Japanese women they tested and they also reported finding evidence of BK-virus-specific IgM in the cord blood of three babies. This was followed by a report from Germany by Rziha and colleagues'0 who found BK-virus-specific IgM in 9 1 % of the cord bloods they tested. Our present results and those from our previous study20 are in agreement with Borgatti and evidence that BK-virus crossed the placenta and infected the fetuses.
As yet there have been no reports on the occurrence of JC-virus-specific IgM. Although we were unable to screen the women in the survey by FA for JC-virusspecific IgM, the studies we did on the sera from the 40 cytologically-positive women and the cord bloods from their babies indicated that JC-virus tends to be reactivated more commonly during pregnancy than BK-virus; JC-virus-specific IgM was detected and confirmed by IEM in seven (l7-5 %) of the women.
This finding can be correlated with those of the previous study20 on this group in which four of the six viruses isolated and identified were JC-virus and only one was BK-virus.
In contrast to our findings with BK-virus, we have evidence that transplacental infection of JC-virus may have occurred in one child whose mother had evidence of a polyomavirus reactivation infection during pregnancy. JC-virus-specific IgM was detected in small amounts in fractionated maternal sera and cord blood by HI, but could only be confirmed by IEM in the maternal sera. In the mother JC-virusspecific IgM was detected early in pregnancy and persisted until delivery. Except 
